Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy.

Abnormal expression of human myotonic dystrophy protein kinase (hDMPK) gene products has been implicated in myotonic dystrophy type 1 (DM1), yet the impact of distress accumulation produced by persistent overexpression of this poorly understood member of the Rho kinase-related protein kinase gene-family remains unknown. Here, in the aged transgenic murine line carrying approximately 25 extra copies of a complete hDMPK gene with all exons and an intact promoter region (Tg26-hDMPK), overexpression of mRNA and protein transgene products in cardiac, skeletal and smooth muscles resulted in deficient exercise endurance, an integrative index of muscle systems underperformance. In contrast to age-matched (11-15 months) wild-type controls, hearts from Tg26-hDMPK developed cardiomyopathic remodeling with myocardial hypertrophy, myocyte disarray and interstitial fibrosis. Hypertrophic cardiomyopathy was associated with a propensity for dysrhythmia and characterized by overt intracellular calcium overload promoting nuclear translocation of transcription factors responsible for maladaptive gene reprogramming. Skeletal muscles in distal limbs of Tg26-hDMPK showed myopathy with myotonic discharges coupled with deficit in sarcolemmal chloride channels, required regulators of hyperexcitability. Fiber degeneration in Tg26-hDMPK resulted in sarcomeric disorganization, centralization of nuclei and tubular aggregation. Moreover, the reduced blood pressure in Tg26-hDMPK indicated deficient arterial smooth muscle tone. Thus, the cumulative stress induced by permanent overexpression of hDMPK gene products translates into an increased risk for workload intolerance, hypertrophic cardiomyopathy with dysrhythmia, myotonic myopathy and hypotension, all distinctive muscle traits of DM1. Proper expression of hDMPK is, therefore, mandatory in supporting the integral balance among cytoarchitectural infrastructure, ion-homeostasis and viability control in various muscle cell types.

[1]  W. Evans.  THE HEART IN MYOTONIA ATROPHICA , 1944, British heart journal.

[2]  W. Engel,et al.  Rapid examination of muscle tissue , 1963, Neurology.

[3]  References , 1971 .

[4]  D. Harman,et al.  The aging process. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Randall,et al.  Myotonic electromyographic activity in complexus muscles of normal and dystrophic chicks , 1982, Muscle & nerve.

[6]  R. Newcombe,et al.  Blood pressure and myotonic dystrophy , 1983, Clinical genetics.

[7]  F. Lehmann-Horn,et al.  Membrane changes in cells from myotonia patients. , 1985, Physiological reviews.

[8]  W. Edwards,et al.  Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. , 1988, Journal of the American College of Cardiology.

[9]  H. Jockusch,et al.  Inactivation of muscle chloride channel by transposon insertion in myotonic mice , 1991, Nature.

[10]  T. Ashizawa,et al.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.

[11]  C. Amemiya,et al.  Characterization of the myotonic dystrophy region predicts multiple protein isoform–encoding mRNAs , 1992, Nature Genetics.

[12]  C. Amemiya,et al.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.

[13]  David E. Housman,et al.  Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.

[14]  C. Amemiya,et al.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect , 1992, Nature.

[15]  B. Wieringa.  COMMENTARY: Myotonic dystrophy reviewed: back to the future? , 1994 .

[16]  B. Wieringa.  Myotonic dystrophy reviewed: back to the future? , 1994, Human molecular genetics.

[17]  K. Campbell,et al.  Absence of the Skeletal Muscle Sarcolemma Chloride Channel ClC-1 in Myotonic Mice (*) , 1995, The Journal of Biological Chemistry.

[18]  J. Gilbert,et al.  Modulation of skeletal muscle sodium channels by human myotonin protein kinase. , 1995, The Journal of clinical investigation.

[19]  A. Berns,et al.  Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.

[20]  K. Tamai,et al.  Overexpression of 3′-Untranslated Region of the Myotonic Dystrophy Kinase cDNA Inhibits Myoblast Differentiation in Vitro* , 1997, The Journal of Biological Chemistry.

[21]  F. Oerlemans,et al.  Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells. , 1997, The Journal of clinical investigation.

[22]  R. Korneluk,et al.  Definition of Regulatory Sequence Elements in the Promoter Region and the First Intron of the Myotonic Dystrophy Protein Kinase Gene* , 1998, The Journal of Biological Chemistry.

[23]  C. McMurray,et al.  Influence of hairpins on template reannealing at trinucleotide repeat duplexes: a model for slipped DNA. , 1998, Biochemistry.

[24]  Gacy Am,et al.  Influence of hairpins on template reannealing at trinucleotide repeat duplexes: a model for slipped DNA. , 1998 .

[25]  D. Housman,et al.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. , 1999, The Journal of clinical investigation.

[26]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[27]  L. Guarente,et al.  Molecular Biology of Aging , 1999, Cell.

[28]  S. Sakoda,et al.  The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy , 2000, Neuroscience Letters.

[29]  D. Turner,et al.  Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. , 2000, RNA.

[30]  B. Wieringa,et al.  Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. , 2000, Human molecular genetics.

[31]  B. Byrne,et al.  Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.

[32]  G. Morris,et al.  Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart. , 2000, Human molecular genetics.

[33]  S. Reddy,et al.  Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. , 2000, Human molecular genetics.

[34]  S. Jin,et al.  Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells. , 2000, Cell motility and the cytoskeleton.

[35]  Takayoshi Kobayashi,et al.  Myotonic dystrophy and myotonic dystrophy protein kinase. , 2000, Progress in histochemistry and cytochemistry.

[36]  D. Hartshorne,et al.  Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity , 2001, FEBS letters.

[37]  A. Terzic,et al.  Directed Inhibition of Nuclear Import in Cellular Hypertrophy* , 2001, The Journal of Biological Chemistry.

[38]  O. Marin,et al.  Myotonic dystrophy protein kinase of the cardiac muscle: Evaluation using an immunochemical approach , 2002, Microscopy research and technique.

[39]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[40]  S. Cannon,et al.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. , 2002, Molecular cell.

[41]  T. Cooper,et al.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.

[42]  A. Terzic,et al.  Kir6.2 is required for adaptation to stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Olson,et al.  Converging Pathways and Principles in Heart Development and Disease CV@CSH , 2002, Cell.

[44]  Godfrey L. Smith,et al.  Abnormal contractile activity and calcium cycling in cardiac myocytes isolated from DMPK knockout mice. , 2003, Physiological genomics.

[45]  B. Wieringa,et al.  Transgenic mouse models for myotonic dystrophy type 1 (DM1) , 2003, Cytogenetic and Genome Research.

[46]  R. Marcos,et al.  Mutagenic stress modulates the dynamics of CTG repeat instability associated with myotonic dystrophy type 1. , 2003, Nucleic acids research.

[47]  A. Terzic,et al.  Structural Adaptation of the Nuclear Pore Complex in Stem Cell–Derived Cardiomyocytes , 2003, Circulation research.

[48]  M. Kasten,et al.  A role for myotonic dystrophy protein kinase in synaptic plasticity. , 2003, Journal of neurophysiology.

[49]  Qingcai Wang,et al.  Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase. , 2003, Physiological genomics.

[50]  B. Wieringa,et al.  Alternative Splicing Controls Myotonic Dystrophy Protein Kinase Structure, Enzymatic Activity, and Subcellular Localization , 2003, Molecular and Cellular Biology.

[51]  E. Olson,et al.  Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.

[52]  A. Terzic,et al.  Cellular remodeling in heart failure disrupts KATP channel‐dependent stress tolerance , 2003, The EMBO journal.

[53]  Y. Kino,et al.  Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology. , 2003, Journal of biochemistry.

[54]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[55]  J. Ross,et al.  Calcium and heart failure: the cycle game , 2003, Nature Network Boston.

[56]  G. Butler-Browne,et al.  Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. , 2003, The American journal of pathology.

[57]  Anne J. Ridley,et al.  ROCKs: multifunctional kinases in cell behaviour , 2003, Nature Reviews Molecular Cell Biology.

[58]  L. Ranum,et al.  Myotonic dystrophy: RNA pathogenesis comes into focus. , 2004, American journal of human genetics.

[59]  A. Terzic,et al.  ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. , 2004, Diabetes.

[60]  A. Terzic,et al.  Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia. , 2004, Diabetes.

[61]  J. Ikeda,et al.  Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR. , 2004, Human molecular genetics.

[62]  M. Mahadevan,et al.  Myogenic defects in myotonic dystrophy. , 2004, Developmental biology.

[63]  A. Terzic,et al.  Stable benefit of embryonic stem cell therapy in myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.

[64]  R. P. Junghans,et al.  RNA Leaching of Transcription Factors Disrupts Transcription in Myotonic Dystrophy , 2004, Science.

[65]  R. Richards,et al.  Dynamic mutations on the move in Banff , 2004, Nature Genetics.

[66]  E. Nanba,et al.  [Myotonic dystrophy]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.